publication venue for
- Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients. 329-336. 2022
- Nasopharyngeal Microbiota as an early severity biomarker in COVID-19 hospitalised patients: a retrospective cohort study in a Mediterranean area. 329-336. 2022
- 2 Post-acute COVID-19 Syndrome. Incidence and risk factors: a Mediterranean cohort study. 378-383. 2021
- Incidence of delayed asymptomatic COVID-19 recurrences in a 6-month longitudinal study. 276-316. 2021
- Low prevalence of post-COVID syndrome in patients with asthma. 302-303. 2021
- Post-acute COVID-19 Syndrome. Incidence and risk factors: a Mediterranean cohort study 2021
- Evaluation of the rapid antigen test Panbio COVID-19 in saliva and nasal swabs in a population-based point-of-care study . 1-3. 2020
- Lack of detrimental effect of corticosteroids on antibody responses to SARS-CoV-2 and viral clearance in patients hospitalized with COVID-19. 30676-30679. 2020
- Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013. 587-596. 2016
- Impact of late presentation of HIV infection on short-, mid- and long-term mortality and causes of death in a multicenter national cohort: 2004-2013.. 587-596. 2016
- Clinical presentation of HIV infection in patients aged 50 years or older. 213-216. 2013
- Corticosteroid therapy in patients with primary viral pneumonia due to pandemic (H1N1) 2009 influenza. 311-318. 2012
- Severe acute renal failure associated with rhabdomyolysis during treatment with raltegravir. A call for caution. . 189-190. 2010
- The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. 166-174. 2006
- The influence of age and gender on the population-based incidente of community-acquired pneumonia caused by different microbial pathogens. 166-174. 2006